IRTC · iRhythm Holdings, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-02 | Turakhia Minang |
CHIEF MED/SCI OFCR EVP ADVTECH |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
1,423 |
| 2026-07-02 | Freeman Sean Clinton |
EVP, Strategy & Corp Devt |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
918 |
| 2026-06-02 | Rosenbaum Marc Wade |
Chief Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
729 |
| 2026-06-02 | Shrishrimal Sumi |
EVP, Chief Risk Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
1,716 |
| 2026-05-29 | Patterson Chad |
CHIEF COMM & PRODUCT OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Patterson is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3. |
Common Stock
|
177 |
| 2026-05-29 | Blackford Quentin S. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Blackford is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3. |
Common Stock
|
178 |
| 2026-05-29 | Rosenbaum Marc Wade |
Chief Accounting Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Rosenbaum is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3. |
Common Stock
|
178 |
| 2026-05-29 | Freeman Sean Clinton |
EVP, Strategy & Corp Devt |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Freeman is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3. |
Common Stock
|
273 |
| 2026-05-29 | Shrishrimal Sumi |
EVP, Chief Risk Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3. |
Common Stock
|
133 |
| 2026-05-29 | Turakhia Minang |
CHIEF MED/SCI OFCR EVP ADVTECH |
Award↑
Filing footnotes — Common Stock (Direct)
Mr. Turakhia is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3. |
Common Stock
|
137 |
| 2026-05-27 | OBOYLE KEVIN C |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. |
Common Stock
|
1,573 |
| 2026-05-27 | MCGINNIS KAREN K |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. |
Common Stock
|
1,573 |
| 2026-05-27 | YOOR BRIAN B |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. |
Common Stock
|
1,573 |
| 2026-05-27 | Bairey Merz Cathleen Noel |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. |
Common Stock
|
1,573 |
| 2026-05-27 | Bodaken Bruce G. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. |
Common Stock
|
1,573 |
| 2026-05-27 | TALWALKAR ABHIJIT Y |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. |
Common Stock
|
1,573 |
| 2026-05-27 | Ling Karen |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting. |
Common Stock
|
1,573 |
| 2026-05-11 | TALWALKAR ABHIJIT Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $116.62 to a high of $117.31, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points. |
Common Stock
|
642 |
| 2026-05-11 | TALWALKAR ABHIJIT Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. |
Common Stock
|
290 |
| 2026-05-11 | TALWALKAR ABHIJIT Y |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. |
Common Stock
|
5,312 |
| 2026-05-11 | TALWALKAR ABHIJIT Y |
Director |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option, originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments. This option has an expiration date of May 23, 2026. The Rule 10b5-1 trading plan of Mr. Talwalkar solely covers shares subject to options expiring in 2026 and 2027. |
Employee Stock Option (right to buy)
|
5,312 |
| 2026-05-11 | TALWALKAR ABHIJIT Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $115.61 to a high of $116.61, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points. |
Common Stock
|
940 |
| 2026-05-11 | TALWALKAR ABHIJIT Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $118.70 to a high of $119.63, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points. |
Common Stock
|
1,147 |
| 2026-05-11 | TALWALKAR ABHIJIT Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $117.68 to a high of $118.45, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points. |
Common Stock
|
2,293 |
| 2026-05-04 | Lawrence Brian Lee |
Chief Technology Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
1,014 |
| 2026-03-16 | Smith Mervin |
EVP Strategic Business Ops |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 19, 2025. |
Common Stock
|
2,585 |
| 2026-03-12 | Patten Jason H |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-03-12 | Patten Jason H |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 33.33% of the RSUs vest on March 12, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
Common Stock
|
2,218 |
| 2026-03-02 | Patterson Chad |
CHIEF COMM & PRODUCT OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
1,414 |
| 2026-03-02 | Rosenbaum Marc Wade |
Chief Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
417 |
| 2026-03-02 | Smith Mervin |
EVP Strategic Business Ops |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
600 |
| 2026-03-02 | Wilson Daniel G. |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
564 |
| 2026-03-02 | Shrishrimal Sumi |
EVP, Chief Risk Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
946 |
| 2026-03-02 | Wilson Daniel G. |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
1,261 |
| 2026-03-02 | Shrishrimal Sumi |
EVP, Chief Risk Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
978 |
| 2026-03-02 | Wilson Daniel G. |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
815 |
| 2026-03-02 | Blackford Quentin S. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
4,347 |
| 2026-03-02 | Shrishrimal Sumi |
EVP, Chief Risk Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
906 |
| 2026-03-02 | Turakhia Minang |
CHIEF MED/SCI OFCR EVP ADVTECH |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
1,310 |
| 2026-03-02 | Murphy Patrick Michael |
CBO and CLO |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
1,190 |
| 2026-03-02 | Murphy Patrick Michael |
CBO and CLO |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
1,139 |
| 2026-03-02 | Patterson Chad |
CHIEF COMM & PRODUCT OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
3,030 |
| 2026-03-02 | Turakhia Minang |
CHIEF MED/SCI OFCR EVP ADVTECH |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
1,230 |
| 2026-03-02 | Murphy Patrick Michael |
CBO and CLO |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
2,028 |
| 2026-03-02 | Smith Mervin |
EVP Strategic Business Ops |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
752 |
| 2026-03-02 | Turakhia Minang |
CHIEF MED/SCI OFCR EVP ADVTECH |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
1,487 |
| 2026-03-02 | Wilson Daniel G. |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
755 |
| 2026-03-02 | Rosenbaum Marc Wade |
Chief Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
399 |
| 2026-03-02 | Blackford Quentin S. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
4,043 |
| 2026-03-02 | Blackford Quentin S. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs). |
Common Stock
|
5,423 |